Jia Jie Biomedical Co Ltd Cash Flow Reinvestment Rate
Jia Jie Biomedical Co Ltd cash flow reinvestment rate. Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Reinvestment Rate of 5.77x as of March 2026, reinvesting NT$74.69 Million (capex NT$5.84 Million plus investments NT$-68.84 Million) from operating cash flow of NT$12.96 Million. See 4109 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jia Jie Biomedical Co Ltd (2015–2025)
Cash flow reinvestment rate of Jia Jie Biomedical Co Ltd from 2015 to 2025. Historical reinvestment intensity for Jia Jie Biomedical Co Ltd across 6 annual periods. Explore 4109 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Jia Jie Biomedical Co Ltd Cash Flow Reinvestment Rate by Year (2015–2025)
Jia Jie Biomedical Co Ltd cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for Jia Jie Biomedical Co Ltd. For the full cash flow conversion analysis, see 4109 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.62x | NT$184.01 Million | NT$21.34 Million | NT$85.50 Million | ▲ +336.0% |
| 2024 | 1.98x | NT$87.70 Million | NT$44.35 Million | NT$19.63 Million | ▼ -94.8% |
| 2021 | 37.72x | NT$164.94 Million | NT$4.37 Million | NT$1.52 Million | ▲ +519.3% |
| 2020 | 6.09x | NT$165.05 Million | NT$27.10 Million | NT$1.63 Million | ▼ -15.8% |
| 2019 | 7.23x | NT$178.78 Million | NT$24.71 Million | NT$3.05 Million | ▲ +114.6% |
| 2015 | 3.37x | NT$277.22 Million | NT$82.22 Million | NT$273.85 Million | — |